SCHEMBL30289396

SCHEMBL30289396

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CN3CCC(OC4CN(C(=O)OC(C)(C)C)C4)CC3)cc21

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 17/20 0.52
▸ CRBN Q96SW2 17/20 0.52
▸ IKZF1 Q13422 1/20 0.35
▸ IKZF2 Q9UKS7 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23832523 0.95 DDB1 (0.56) DDB1CRBN
SCHEMBL30289064 0.95 DDB1 (0.54) DDB1CRBN
SCHEMBL31003887 0.94 DDB1 (0.54) DDB1CRBN
SCHEMBL26853831 0.94 DDB1 (0.54) DDB1CRBN
SCHEMBL21997585 0.90 CRBN (0.58) DDB1CRBN
SCHEMBL30733862 0.89 DDB1 (0.57) DDB1CRBN
SCHEMBL25934691 0.89 DDB1 (0.57) DDB1CRBN
SCHEMBL26634955 0.88 DDB1 (0.56) DDB1CRBN
SCHEMBL26634898 0.88 DDB1 (0.56) DDB1CRBN
SCHEMBL26634984 0.87 DDB1 (0.52) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 — — EP disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 — — WO disclosed
Send feedback